Quantcast

Divided FDA panel urges more Avandia warnings, restrictions (access required)
Large group of members votes to pull drug from market entirely

By: Kimberly Atkins
Published: July 15, 2010

Tags: , ,

WASHINGTON - In a fractured vote Wednesday, a significant number of members of an advisory committee for the Food and Drug Administration voted in favor of removing the controversial diabetes drug Avandia from the market in light of a reported increased risk of heart attack and other health problems.
© Copyright 2013 Lawyers USA. All Rights Reserved.


POST A COMMENT

 

Sign-up for alerts

FEATURED PODCAST


Lawyers USA presents Lawyers in Practice

This is the first edition of Lawyers USA's Lawyers in Practice, where we discuss the hot issues facing practicing attorneys and law firms.

In this edition, we discuss how to prevent legal malpractice claims with better communication, with Jim Calloway, director of the Oklahoma Bar Association's Management Assistance Program, and Dan Pinnington, vice-president of Claims Prevention and Stakeholder Relations at LawPRO, a professional liability carrier based in Toronto, Canada.

Visit the Legal Malpractice Monitor to listen to the podcast.

Click here to download the podcast.